Multicenter, phase I, dose-escalation trial of lenalidomide plus bortezomib for relapsed and relapsed/refractory multiple myeloma.

Details

Language :

English

ISSN :

0732183X

Volume :

27

Issue :

34

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105252303

Full Text :

https://doi.org/10.1200/JCO.2009.22.2679